281 related articles for article (PubMed ID: 19576214)
1. Reduction in endothelial tip cell filopodia corresponds to reduced intravitreous but not intraretinal vascularization in a model of ROP.
Budd S; Byfield G; Martiniuk D; Geisen P; Hartnett ME
Exp Eye Res; 2009 Nov; 89(5):718-27. PubMed ID: 19576214
[TBL] [Abstract][Full Text] [Related]
2. Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity.
Geisen P; Peterson LJ; Martiniuk D; Uppal A; Saito Y; Hartnett ME
Mol Vis; 2008 Feb; 14():345-57. PubMed ID: 18334951
[TBL] [Abstract][Full Text] [Related]
3. Endothelial NADPH oxidase 4 mediates vascular endothelial growth factor receptor 2-induced intravitreal neovascularization in a rat model of retinopathy of prematurity.
Wang H; Yang Z; Jiang Y; Hartnett ME
Mol Vis; 2014; 20():231-41. PubMed ID: 24623966
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity.
Saito Y; Geisen P; Uppal A; Hartnett ME
Mol Vis; 2007 Jun; 13():840-53. PubMed ID: 17615545
[TBL] [Abstract][Full Text] [Related]
5. Anti-VEGF antibody leads to later atypical intravitreous neovascularization and activation of angiogenic pathways in a rat model of retinopathy of prematurity.
McCloskey M; Wang H; Jiang Y; Smith GW; Strange J; Hartnett ME
Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):2020-6. PubMed ID: 23449716
[TBL] [Abstract][Full Text] [Related]
6. Association of retinal vascular endothelial growth factor with avascular retina in a rat model of retinopathy of prematurity.
Budd SJ; Thompson H; Hartnett ME
Arch Ophthalmol; 2010 Aug; 128(8):1014-21. PubMed ID: 20697002
[TBL] [Abstract][Full Text] [Related]
7. CM082, a novel VEGF receptor tyrosine kinase inhibitor, can inhibit angiogenesis in vitro and in vivo.
Dan H; Lei X; Huang X; Ma N; Xing Y; Shen Y
Microvasc Res; 2021 Jul; 136():104146. PubMed ID: 33610563
[TBL] [Abstract][Full Text] [Related]
8. The role of supplemental oxygen and JAK/STAT signaling in intravitreous neovascularization in a ROP rat model.
Byfield G; Budd S; Hartnett ME
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3360-5. PubMed ID: 19264880
[TBL] [Abstract][Full Text] [Related]
9. Expression of vascular endothelial growth factor and pigment epithelial-derived factor in a rat model of retinopathy of prematurity.
Hartmann JS; Thompson H; Wang H; Kanekar S; Huang W; Budd SJ; Hartnett ME
Mol Vis; 2011; 17():1577-87. PubMed ID: 21738387
[TBL] [Abstract][Full Text] [Related]
10. RNA-Seq Provides Insights into VEGF-Induced Signaling in Human Retinal Microvascular Endothelial Cells: Implications in Retinopathy of Prematurity.
Ramshekar A; Bretz CA; Hartnett ME
Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806359
[TBL] [Abstract][Full Text] [Related]
11. Triamcinolone reduces neovascularization, capillary density and IGF-1 receptor phosphorylation in a model of oxygen-induced retinopathy.
Hartnett ME; Martiniuk DJ; Saito Y; Geisen P; Peterson LJ; McColm JR
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4975-82. PubMed ID: 17065516
[TBL] [Abstract][Full Text] [Related]
12. Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model.
Saito Y; Uppal A; Byfield G; Budd S; Hartnett ME
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1591-8. PubMed ID: 18385079
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor receptor-2 inhibition promotes cell death and limits endothelial cell proliferation in a neonatal rodent model of stroke.
Shimotake J; Derugin N; Wendland M; Vexler ZS; Ferriero DM
Stroke; 2010 Feb; 41(2):343-9. PubMed ID: 20101028
[TBL] [Abstract][Full Text] [Related]
14. Studies on the pathogenesis of avascular retina and neovascularization into the vitreous in peripheral severe retinopathy of prematurity (an american ophthalmological society thesis).
Hartnett ME
Trans Am Ophthalmol Soc; 2010 Dec; 108():96-119. PubMed ID: 21212851
[TBL] [Abstract][Full Text] [Related]
15. Increased angiogenic factors associated with peripheral avascular retina and intravitreous neovascularization: a model of retinopathy of prematurity.
Budd SJ; Hartnett ME
Arch Ophthalmol; 2010 May; 128(5):589-95. PubMed ID: 20457980
[TBL] [Abstract][Full Text] [Related]
16. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
Kim KL; Suh W
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
[TBL] [Abstract][Full Text] [Related]
17. Enhancing Retinal Endothelial Glycolysis by Inhibiting UCP2 Promotes Physiologic Retinal Vascular Development in a Model of Retinopathy of Prematurity.
Han X; Kong J; Hartnett ME; Wang H
Invest Ophthalmol Vis Sci; 2019 Apr; 60(5):1604-1613. PubMed ID: 30995317
[TBL] [Abstract][Full Text] [Related]
18. Targeting Müller cell-derived VEGF164 to reduce intravitreal neovascularization in the rat model of retinopathy of prematurity.
Jiang Y; Wang H; Culp D; Yang Z; Fotheringham L; Flannery J; Hammond S; Kafri T; Hartnett ME
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):824-31. PubMed ID: 24425851
[TBL] [Abstract][Full Text] [Related]
19. Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor-2 inhibitor.
Xie C; Wan X; Quan H; Zheng M; Fu L; Li Y; Lou L
Cancer Sci; 2018 Apr; 109(4):1207-1219. PubMed ID: 29446853
[TBL] [Abstract][Full Text] [Related]
20. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH
Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
